Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Inés Pérez-Román"'
Autor:
Jaime Rodríguez Quintosa, Cintia Cristina Ago, Antoni Sicras Mainar, Renata Villoro, Inés Pérez-Román
Publikováno v:
Global & Regional Health Technology Assessment, Vol 9, Iss 1 (2022)
Background: Impetigo is a common dermatological paediatric infection that can be treated with topical antibiotics: the common are mupirocin (MUP), fusidic acid (FA) and, most recently, ozenoxacin (OZ). Aim: This study assesses the clinical and econo
Externí odkaz:
https://doaj.org/article/95958a75673c488f94ae2a01b65864c7
Autor:
Santiago Bonanad, María Teresa Álvarez, Ramiro Núñez, José Luis Poveda, Beatriz Gil, Elena Ruíz-Beato, Ana Durán, Yoana Ivanova, Inés Pérez-Román, Almudena González-Domínguez
Publikováno v:
Global & Regional Health Technology Assessment, Vol 8 (2021)
Introduction: Emicizumab is a first-in-class monoclonal antibody, recently authorized for the treatment of hemophilia A with inhibitors. This study aims to estimate the direct and indirect costs of the management of hemophilia A with inhibitors, in a
Externí odkaz:
https://doaj.org/article/4175ad5d84ca44c7858d1b089c0f955b
Autor:
Ana Durán, Ramiro Núñez, Inés Pérez-Román, Elena Ruiz-Beato, Yoana Ivanova, Santiago Bonanad, José Luis Poveda, Almudena González-Domínguez, M. T. Alvarez, Beatriz Gil
Publikováno v:
Global & Regional Health Technology Assessment, Vol 8 (2021)
GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Introduction: Emicizumab is a first-in-class monoclonal antibody, recently authorized for the treatment of hemophilia A with inhibitors. This study aims to estimate the direct and indirect costs of the management of hemophilia A with inhibitors, in a
Autor:
José Sanz-Moreno, Álvaro Hidalgo-Vega, Antonio Castro-Gómez, Rocío Montejano, Robert Güerri-Fernández, Juan Carlos Figueira, Inés Pérez-Román, Santiago Grau, Almudena González-Domínguez, Alejandro Soriano
Publikováno v:
Advances in Therapy
Introduction Spain was one of the most affected countries during the first wave of COVID-19, having the highest mortality rate in Europe. The aim of this retrospective study is to estimate the impact that remdesivir—the first drug for COVID-19 appr
Autor:
Alejandro Soriano, Rocío Montejano, José Sanz Moreno, Juan Carlos Figueira, Santiago Grau, Robert Güerri-Fernández, Antonio Castro-Gomez, Inés Pérez-Román, Álvaro Hidalgo-Vega, Almudena González-Domínguez
Background: Spain was one of the most affected countries during the first wave of COVID-19, having the highest mortality rate in Europe. The aim of this retrospective study is to estimate the impact that remdesivir -the first drug for COVID-19 approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d49ffc928573389d1d64deb10690c7f
https://doi.org/10.21203/rs.3.rs-337288/v1
https://doi.org/10.21203/rs.3.rs-337288/v1
Autor:
Ana Beatriz Sánchez-Heras, Almudena González-Domínguez, Susana Simón, Antonio González-Martín, Inés Pérez-Román, Eloisa Bayo-Lozano, Carlota Moya-Alarcón
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 21(8)
Germline mutations in BRCA1 and/or BRCA2 genes (gBRCA1/2m) are associated with an increased risk of breast cancer (BC) and ovarian cancer (OC). The aim of this study was to estimate the efficiency of providing germline BRCA1/2 testing to high-grade e
Autor:
Ines Perez-Roman, Filip Kiekens, Damian Cordoba-Diaz, Juan Jose Garcia-Rodriguez, Manuel Cordoba-Diaz
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 873 (2020)
Background: Intestinal nematode infections are usually treated with benzimidazole drugs, but the emergence of resistance to these drugs has led to an increasing demand of new anthelmintic strategies. A new microemulsion formulation (ME) consisting of
Externí odkaz:
https://doaj.org/article/24ed1fa821c645b5b07315804ce2083b
Autor:
Vivencio Barrios, Mar Castellanos, Raquel Campuzano Ruiz, Jorge Francisco Gómez Cerezo, Isabel Egocheaga Cabello, José M. Gámez, Icíar Martínez López, José María Mostaza, Nuria Morant Talamante, Javier Parrondo, Aram Sicras Navarro, Inés Pérez Román, Antoni Sicras-Mainar, Vicente Pallarés-Carratalá
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundAtherosclerotic cardiovascular diseases (ASCVD) and dyslipidemia are associated to a higher risk of cardiovascular events, mortality, use of healthcare resources and costs. In Spain, the evidence about the administration of lipid-lowering t
Externí odkaz:
https://doaj.org/article/4b9af8a92dc349f887b59834e574566b